METSYSTEM
Targeting Metastasis, transforming treatment
Munich, Denmark · Founded 2023 · $529K raised
- Headquarters
- Munich
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- metsystem.dk
- Total Funding
- $529K
- Last Round
- $529K GrantMar 2023
- Rounds
- 1
About
Metsystem develops METscreen, an advanced drug screen platform using patient-derived organoids and metastasis-targeting technologies to predict if and where cancer will spread and identify the most effective treatment for each patient. By bridging cutting-edge science with clinical application, Metsystem empowers doctors to make precise, informed treatment decisions based on the cancer's actual response.
Summary
METSYSTEM is a Healthcare company based in Munich, Denmark, founded in 2023. It has raised $529K in total across 1 round, most recently a $529K Grant round in Mar 2023. Investors include BioInnovation Institute.
Tech & App Stack
9 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2023
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Hyland provides content services and intelligent automation solutions for enterprises.
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...